These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18496462)

  • 21. Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma.
    Storto G; Di Giorgio E; De Renzo A; Pizzuti LM; Cerciello G; Nardelli A; Capacchione D; Castaldi E; Ortosecco G; Pace L
    Br J Haematol; 2010 Oct; 151(2):195-7. PubMed ID: 20735395
    [No Abstract]   [Full Text] [Related]  

  • 22. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
    J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and localization of renal cyst infection by 18F-fluorodeoxyglucose PET/CT in polycystic kidney disease.
    Soussan M; Sberro R; Wartski M; Fakhouri F; Pecking AP; Alberini JL
    Ann Nucl Med; 2008 Jul; 22(6):529-31. PubMed ID: 18670861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET/CT for therapy response assessment in lymphoma.
    Hutchings M; Barrington SF
    J Nucl Med; 2009 May; 50 Suppl 1():21S-30S. PubMed ID: 19380407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
    J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-FDG PET after radiofrequency ablation: Is timing everything?
    Avril N
    J Nucl Med; 2006 Aug; 47(8):1235-7. PubMed ID: 16882998
    [No Abstract]   [Full Text] [Related]  

  • 28. 18F-FDG-PET/CT as an indicator for resection of pulmonary epithelioid hemangioendothelioma.
    Watanabe S; Yano F; Kita T; Soga S; Shinmoto H; Kosuda S; Ozeki Y; Aida S; Sakata I
    Ann Nucl Med; 2008 Jul; 22(6):521-4. PubMed ID: 18670859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients.
    Saif MW; Cornfeld D; Modarresifar H; Ojha B
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):173-8. PubMed ID: 18568138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
    Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE
    Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography/computed tomography: the current technology and applications.
    Mittra E; Quon A
    Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
    Schwarz JK; Grigsby PW; Dehdashti F; Delbeke D
    J Nucl Med; 2009 May; 50 Suppl 1():64S-73S. PubMed ID: 19380409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-to-time correlation of high-risk atherosclerotic lesions identified with [(18)F]-FDG-PET/CT.
    Wassélius J; Larsson S; Jacobsson H
    Ann Nucl Med; 2009 Jan; 23(1):59-64. PubMed ID: 19205839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute respiratory distress syndrome suggested by ¹⁸F-FDG PET/CT.
    Ozhan M; Yilmaz S; Aliyev A; Varoglu E; Halac M; Kantarci F
    Hell J Nucl Med; 2012; 15(1):72-3. PubMed ID: 22413121
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.
    Kuehl H; Rosenbaum-Krumme S; Veit-Haibach P; Stergar H; Forsting M; Bockisch A; Antoch G
    Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.
    D'souza MM; Sharma R; Mondal A; Jaimini A; Tripathi M; Saw SK; Singh D; Mishra A; Tripathi RP
    Nucl Med Commun; 2009 Feb; 30(2):117-25. PubMed ID: 19057427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomography/computed tomography for staging and restaging of head and neck cancer: comparison with positron emission tomography read together with contrast-enhanced computed tomography.
    Goerres GW; Schuknecht B; Schmid DT; Stoeckli SJ; Hany TF
    Clin Imaging; 2008; 32(6):431-7. PubMed ID: 19006770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
    Krause BJ; Herrmann K; Wieder H; zum Büschenfelde CM
    J Nucl Med; 2009 May; 50 Suppl 1():89S-96S. PubMed ID: 19380406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [FDG PET/CT and childhood Hodgkin lymphoma].
    Montravers F; Kerrou K; Huchet V; Pascal O; Talbot JN
    Arch Pediatr; 2009 Jun; 16(6):669-71. PubMed ID: 19541124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.